ARHGDIB Monoklonaler Antikörper
ARHGDIB Monoklonal Antikörper für WB, IHC, IF-P, Indirect ELISA
Wirt / Isotyp
Maus / IgG2b
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IF-P, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
3E7B7
Kat-Nr. : 66054-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66054-1-PBS bindet in WB, IHC, IF-P, Indirect ELISA ARHGDIB und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Maus / IgG2b |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | ARHGDIB fusion protein Ag9091 |
| Vollständiger Name | Rho GDP dissociation inhibitor (GDI) beta |
| Berechnetes Molekulargewicht | 201 aa, 23 kDa |
| Beobachtetes Molekulargewicht | 27 kDa |
| GenBank-Zugangsnummer | BC009200 |
| Gene symbol | ARHGDIB |
| Gene ID (NCBI) | 397 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
ARHGDIB, also known as RhoGDI2, is a conserved member of the RhoGDI family and plays an important role in cell migrations. It regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. It is mainly in hematopoietic, endothelial, and epithelial cells. It has been linked to tumorigenesis and metastasis. RhoGDI2 expression is downregulated in several cancer types, such as bladder, lung and lymphoma, but is upregulated in prostate and gastric cancer.













